Download PDF
Pharmacopsychiatry 2017; 50(03): 107-113
DOI: 10.1055/s-0042-122711
Review
© Georg Thieme Verlag KG Stuttgart · New York

Methamphetamine Consumption during Pregnancy – Effects on Child Health

Jürgen Dinger
1   Department of Child and Adolescent Medicine, University Hospital Carl Gustav Carus Dresden
,
Patricia Hinner
1   Department of Child and Adolescent Medicine, University Hospital Carl Gustav Carus Dresden
,
Jörg Reichert
1   Department of Child and Adolescent Medicine, University Hospital Carl Gustav Carus Dresden
,
Mario Rüdiger
1   Department of Child and Adolescent Medicine, University Hospital Carl Gustav Carus Dresden
› Author Affiliations
Further Information

Publication History

received11 May 2016
revised  23 November 2016

accepted 28 November 2016

Publication Date:
08 February 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Methamphetamine abuse during pregnancy represents an emerging health care problem. The consequences are not only of relevance to the pregnant women, but also their unborn child. It is associated with an increased risk of preeclampsia and hypertension, fetal demise, preterm delivery, and intrauterine growth restriction. The deleterious effects of prenatal methamphetamine exposure on the developing fetal brain may lead to long-term neuro-developmental and behavioral problems.

Given the current evidence, abuse of methamphetamine during pregnancy must be of utmost concern to health care professionals and to policy-makers. As it has been described for neonatal abstinence syndrome, a multi-professional team is required to improve care of affected women and families. A multi-disciplinary approach is needed, including good prenatal care of pregnant women, perinatal care by specialized obstetricians and neonatologists, and psychiatric treatment by an addiction specialist. Furthermore, families should be integrated into appropriate social support networks.

For the development of a structured support program for pregnant women with methamphetamine consumption, methamphetamine use disorder should be considered as a disease that requires medical treatment as well as psychological and social support. The pregnancy should be considered as a window of opportunity to provide the required help.

Key words

prenatal methamphetamine exposure - child’s development - methamphetamin abuse of pregnant women
 

  • References

  • 1 Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend 2014; 143: 11-21
    CrossrefPubMedGoogle Scholar
  • 2 McAvoy BR. Methamphetamine – what primary care practitioners need to know. J Prim Health Care 2009; 1: 170-176
    PubMedGoogle Scholar
  • 3 Brecht ML, Herbeck DM. Pregnancy and fetal loss reported by methamphetamine-using women. Subst Abuse 2014; 8: 25-33
    PubMedGoogle Scholar
  • 4 Volkow ND, Koob GF, McLellan T. Neurobiologic advances from the brain disease model of addiction. N Engl J Med 2016; 374: 363-371
    CrossrefPubMedGoogle Scholar
  • 5 Lewis D. We were wrong about “crack babies”: are we repeating our mistakes with “meth babies”?. MedGenMed 2005; 7: 30
    PubMedGoogle Scholar
  • 6 National drug threat assessment, 2011. Washington, D.C.: Department of Justice, National Drug Intelligence Center; 2011
  • 7 Kershaw C, Nicolas NS, Walker A. Crime in England and Wales 2007/08. Findings from the British Crime Survey and police recorded crime. Home Office Statistical Bulletin 2008
    PubMed
  • 8 Stolle M, Sack PM, Thomasius R. Substance abuse in children and adolescents – early detection and intervention. Dtsch Arztebl 2007; 104: A2061-A2070
    PubMedGoogle Scholar
  • 9 Moore DG, Turner JD, Parrott AC. et al. During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. J Psychopharmacol 2010; 24: 1403-1410
    CrossrefPubMedGoogle Scholar
  • 10 Vega WA, Koloby B, Hwang J. et al. Prevalence and magnitude of perinatal substance exposures in California. New Engl J 1993; 329: 850-854
    CrossrefPubMedGoogle Scholar
  • 11 Gorman MC, Orme KS, Nguyen NT. et al. Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol 2014; 211: 429
    PubMedGoogle Scholar
  • 12 Buchi KF, Suarez C, Varner MW. The prevalence of prenatal opioid and other drug use in Utah. Am J Perinatol 2013; 30: 241-244
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Joya X, Marchei E, Salat-Batlle J. et al. Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption. Drug Test Anal 2016; 8: 864-868
    CrossrefPubMedGoogle Scholar
  • 14 Rausgaard NLK, Ibseb IO, Jorgensen JS. et al. Prevalence of substance abuse in pregnancy among Danish women. Acta Obstetricia et Gynecologia Scandinavica 2015; 94: 215-219
    PubMedGoogle Scholar
  • 15 Wygold T. Das Krankheitsbild des Neonatalen Drogenentzugs. Kinderärztliche Praxis 2006; 77: 148-152
    PubMedGoogle Scholar
  • 16 McDonnell-Dowling K, Kelly JP. Sources of variation in the design of preclinical studies assessing the effects of amphetamine-type stimulants in pregnancy and lactation. Behav Brain Res 2015; 279: 87-99
    CrossrefPubMedGoogle Scholar
  • 17 McDonnell-Dowling K, Kelly JP. Does route of methamphetamine exposure during pregnancy have an impact on neonatal development and behaviour in rat offspring?. Int J Dev Neurosci 2016; 49: 14-22
    CrossrefPubMedGoogle Scholar
  • 18 Carter RC, Wainwright H, Molteno CD. et al. Alcohol, methamphetamine, and marijuana exposure have distinct effects on the human placenta. Alcohol Clin Exp Res 2016; 40: 753-764
    Google Scholar
  • 19 American College of Obstetricians and Gynecologists. Committee Opinion No. 479. Methamphetamine abuse in women of reproductive age. Obstet Gynecol 2011; 117: 751-755
    CrossrefPubMedGoogle Scholar
  • 20 Kwiatkowski MA, Roos A, Stein DJ. et al. Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies. Metab Brain Res 2014; 29: 245-254
    PubMedGoogle Scholar
  • 21 Koob GF. Neural mechanisms of drug reinforcement. Ann N Y Acad Sci 1992; 654: 171-191
    CrossrefPubMedGoogle Scholar
  • 22 Wise RA. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 2008; 14: 169-183
    CrossrefPubMedGoogle Scholar
  • 23 Schultz W. Getting formal with dopamine and reward. Neuron 2002; 36: 241-263
    CrossrefPubMedGoogle Scholar
  • 24 Liles BD, Newman E, LaGasse LL. et al. Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users. Child Psychiatry Hum Dev 2012; 43: 943-957
    CrossrefPubMedGoogle Scholar
  • 25 Orlando S. An overview of clinical tools used to assess neonatal abstinence syndrome. J Perinat Neonat Nurs 2014; 28: 212-219
    CrossrefPubMedGoogle Scholar
  • 26 Smith LM, LaGasse LL, Derauf C. et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 2008; 157: 20-28
    PubMedGoogle Scholar
  • 27 Shah R, Diaz SD, Arria A. et al. Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. Am J Perinatol 2012; 29: 391-400
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 LaGasse LL, Derauf C, Smith LM. et al. Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics 2012; 129: 681-688
    CrossrefPubMedGoogle Scholar
  • 29 Garcia-Bournissen F, Rokach B, Karaskov T. et al. Methamphetamine detection in maternal and neonatal hair: implications for fetal safety. Arch Dis Child Fetal Neonatal Ed 2007; 92: 351-355
    CrossrefPubMedGoogle Scholar
  • 30 Bartu A, Dusci LJ, Ilett KF. Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. Br J Clin Pharmacol 2009; 67: 455-459
    CrossrefPubMedGoogle Scholar
  • 31 Chomchai Ch, Chomchai S, Kitsommart R. Transfer of methamphetamine (MA) into breast milk and urine of postpartum women who smoked MA tablets during pregnancy. Implications for initiation of breastfeeding. J Hum Lact 2016; 32: 333-339
    CrossrefPubMedGoogle Scholar
  • 32 Sirova J, Kristofikova Z, Vrajova M. et al. Sex-dependent changes in striatal dopamine transport in preadolescent rats exposed prenatally and/or postnatally to methamphetamine. Neurochem Res 2016; 41: 1911-1923
    CrossrefPubMedGoogle Scholar
  • 33 Rorabaugh BR, Seeley SL, Bui AD. et al. Prenatal methamphetamine differentially alters myocardial sensitivity to ischemic injury in male and female adult hearts. Am J Physiol Heart Circ Physiol 2016; 310: H516-H523
    CrossrefPubMedGoogle Scholar
  • 34 Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol 2008; 29: 36-47
    CrossrefPubMedGoogle Scholar
  • 35 Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian Hormones. In: Neill JC, Kulkarni J. eds. Biological Basis of Sex Differences in Psychopharmacology. Vol 8: Current Topics in Behavioral Neurosciences. Berlin & Heidelberg: Springer; 2011: 73-96
    Google Scholar
  • 36 Salisbury AL, Ponder KL, Padbury JF. et al. Fetal effects of psychoactive drugs. Clin Perinatol 2009; 36: 595-619
    CrossrefPubMedGoogle Scholar
  • 37 Smith LM, LaGasse LL, Derauf C. et al. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol 2011; 33: 176-184
    CrossrefPubMedGoogle Scholar
  • 38 Billing L, Erikson M, Steneroth G. et al. Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy. Child Abuse Negl 1988; 12: 503-507
    CrossrefPubMedGoogle Scholar
  • 39 Diaz SD, Smith LM, LaGasse LL. et al. Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. J Pediatr 2014; 164: 1333-1338
    CrossrefPubMedGoogle Scholar
  • 40 Billing L, Erikson M, Jonsson B. et al. The influence of environmental factors on behavioural problems in 8-year-old children exposed to amphetamine during fetal life. Child Abuse Negl 1994; 18: 3-9
    CrossrefPubMedGoogle Scholar
  • 41 Cernerud L, Erikson M, Jonsson B. et al. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta Pediatr 1996; 85: 204-208
    CrossrefPubMedGoogle Scholar
  • 42 Piper BJ, Gray HM, Corbett SM. et al. Executive function and mental health in adopted children with a history of recreational drug exposures. PLoS One 2014; 9: e110459
    CrossrefPubMedGoogle Scholar
  • 43 Twomey J, LaGasse L, Derauf C. et al. Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioural problems at 5 years. Am J Orthopsychiatry 2013; 83: 64-72
    CrossrefPubMedGoogle Scholar
  • 44 Kirlic N, Newman E, LaGasse LL. et al. Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine. J Stud Alcohol Drugs 2013; 74: 447-451
    CrossrefPubMedGoogle Scholar
  • 45 Cadet JL. Epigenetics of stress, addiction, and resilience: therapeutic implications. Mol Neurobiol 2016; 53: 545-560
    CrossrefPubMedGoogle Scholar
  • 46 Patrick SW, Schumacher RE, Horbar JD. et al. Improving care for neonatal abstinence syndrome. Pediatrics 2016; 137: e20153835
    CrossrefPubMedGoogle Scholar
  • 47 Wu M, LaGasse LL, Wouldes TA. et al. Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States. Matern Child Health J 2013; 17: 566-575
    CrossrefPubMedGoogle Scholar
  • 48 St-André M, Keren M. Clinical challenges of adoption: views from Montreal and Tel Aviv. Infant Ment Health J 2011; 32: 694-706
    CrossrefPubMedGoogle Scholar
  • 49 Juffer F, Palacios J, Le Mare L. et al. Development of adopted children with histories of early adversity. Monogr Soc Res Child Dev 2011; 76: 31-61
    CrossrefPubMedGoogle Scholar